FDA Approved: EPOPROSTENOL — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves a supplemental application for epoprostenol submitted by Sun Pharmaceutical Industries, Inc., under the ANDA. The action updates the product under …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Epoprostenol (Epoprostenol)

Snippet

SUPPL AP for EPOPROSTENOL (EPOPROSTENOL)